Comparison of warfarin, low-molecular-weight dextran, aspirin, and subcutaneous heparin in prevention of venous thromboembolism following total hip replacement

J Bone Joint Surg Am. 1974 Dec;56(8):1552-62.
No abstract available

Publication types

  • Comparative Study
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Aspirin / adverse effects
  • Aspirin / therapeutic use*
  • Dextrans / adverse effects
  • Dextrans / therapeutic use*
  • Female
  • Hemorrhage / chemically induced
  • Heparin / administration & dosage
  • Heparin / adverse effects
  • Heparin / therapeutic use*
  • Hip Joint* / surgery
  • Humans
  • Injections, Subcutaneous
  • Joint Prosthesis*
  • Male
  • Middle Aged
  • Molecular Weight
  • Postoperative Complications / prevention & control*
  • Prospective Studies
  • Pulmonary Embolism / prevention & control
  • Radiography
  • Thromboembolism / diagnostic imaging
  • Thromboembolism / etiology
  • Thromboembolism / prevention & control*
  • Thrombophlebitis / diagnostic imaging
  • Thrombophlebitis / etiology
  • Thrombophlebitis / prevention & control
  • Warfarin / adverse effects
  • Warfarin / therapeutic use

Substances

  • Dextrans
  • Warfarin
  • Heparin
  • Aspirin